Mutations of the human ATP6V1B1 gene cause distal renal tubular acidosis (dRTA; OMIM #267300) often associated with sensorineural hearing impairment; however, mice with a knockout mutation of Atp6v1b1 were reported to exhibit a compensated acidosis and normal hearing. We discovered a new spontaneous mutation (vortex, symbol vtx) of Atp6v1b1 in an MRL/MpJ (MRL) colony of mice. In contrast to the reported phenotype of the knockout mouse, which was developed on a primarily C57BL/6 (B6) strain background, MRL-Atp6v1b1 vtx/vtx mutant mice exhibit profound hearing impairment, which is associated with enlarged endolymphatic compartments of the inner ear. Mutant mice have alkaline urine but do not exhibit overt metabolic acidosis, a renal phenotype similar to that of the Atpbv1b1 knockout mouse. The abnormal inner ear phenotype of MRL-Atp6v1b1 vtx/vtx mice was lost when the mutation was transferred onto the C57BL/6J (B6) background, indicating the influence of strain-specific genetic modifiers. To genetically map modifier loci in Atp6v1b1 vtx/vtx mice, we analysed ABR thresholds of progeny from a backcross segregating MRL and B6 alleles. We found statistically significant linkage with a locus on Chr 13 that accounts for about 20% of the hearing threshold variation in the backcross mice. The important effect that genetic background has on the inner ear phenotype of Atp6v1b1 mutant mice provides insight into the hearing loss variability associated with dRTA caused by ATP6V1B1 mutations. Because MRL-Atp6v1b1 vxt/vtx mice do not recapitulate the metabolic acidosis of dRTA patients, they provide a new genetic model for nonsyndromic deafness with enlarged vestibular aqueduct (EVA; OMIM #600791).
Introduction
Many of the transport proteins that are involved in acid secretion and bicarbonate reabsorption in the kidney have similar functions in the inner ear (1) . The vacuolar (v)H þ -ATPase pump is one of the key membrane transporters for acid excretion in the a-intercalated cells of the distal nephron, and it is also expressed in the inner ear where it functions in endolymph pH homeostasis (2) . vH þ -ATPase is a large multi-subunit complex consisting of both cytosolic (V 1 ) and transmembrane (V 0 ) domains. Distal renal tubular acidosis (dRTA) caused by vH þ -ATPase mutations (OMIM 267300, 602722) is an autosomal recessive disorder of renal H þ transport causing a buildup of acid in the bloodstream (metabolic acidosis) with associated alkaline urine; it is frequently accompanied by sensorineural hearing loss. dRTA with hearing loss is caused by mutations in the ATP6V1B1 gene (2, 3) , which encodes the B1 subunit of the cytosolic domain of vH þ -ATPase, and with mutations in the ATP6V0A4 gene (3, 4) , which encodes the a4 subunit of the transmembrane domain. In contrast to the ubiquitous expression of most other vH þ -ATPase subunits, expression of the B1 and a4 subunits appears to be primarily restricted to the inner ear and kidney, in complexes that mediate H þ transport across the plasma membrane rather than across the membranes of intracellular organelles (5) . The Atp6v0a4 À/À knockout mouse, which is on a pure C57BL/ 6 strain background, recapitulates the systemic metabolic acidosis and hearing loss phenotype seen in human dRTA patients (6, 7) . In contrast, Atp6v1b1 À/À knockout mice exhibit a mild compensated acidosis (alkaline urine with impaired handling of an acid load) (8) and have normal hearing (9) . A compensatory membrane expression of the vH þ -ATPase B2 subunit was proposed as a possible explanation for why Atp6v1b1 À/À knockout mice under baseline conditions are healthy and do not exhibit the overt metabolic acidosis and symptoms (growth retardation, failure to thrive) characteristic of dRTA patients with ATP6V1B1 mutations (8) . In support of this hypothesis, B2-containing H þ -ATPase complexes, which normally localize to intracellular organelles, were shown to relocalize to the apical membranes of renal intercalated cells in B1-deficient Atp6v1b1 À/À knockout mice (10) . In the mouse inner ear, Atp6v1b1 expression has been detected in the epithelial cells of the endolymphatic sac and duct and in the interdental cell layer of the cochlear spiral limbus (2, 9) . The inner ear expression pattern and the deafness that is associated with ATP6V1B1 mutations in human dRTA patients suggest that ATP6V1B1 plays an important role in pH balance in the mouse inner ear. The surprising finding that Atp6v1b1 À/À knockout mice have normal hearing (9) , however, implies that redundant mechanisms of pH regulation can compensate for the loss of the vH þ -ATPase B1 subunit in the mouse inner ear. This compensation may come from relocalization of B2-containing vH þ -ATPase complexes from intracellular to apical membranes as proposed for renal cells, or it may be accomplished by other acid-base transporting mechanisms or pH buffering systems in the inner ear.
Here, we describe the genetic and phenotypic characterization of a new spontaneous mouse mutation of the Atp6v1b1 gene, named vortex (vtx) for the circling behavior that first identified mutant mice. Mice homozygous for this recessive mutation exhibit auditory and vestibular dysfunction associated with enlarged endolymphatic compartments of their inner ears, phenotypic features that were not observed in the previously reported Atp6v1b1 À/À knockout mouse (9) but that are similar to those of Atp6v0a4 À/À knockout mice (6) . Mice homozygous for a genetically engineered Atp6v1b1 -knockout allele, produced by replacing exons 7-11 with a Neo cassette, were characterized on a primarily C57BL/6 (B6) background with some admixture from 129S1-derived CJ7 ES cells (8) , whereas the spontaneous Atp6v1b1 vtx missense mutation arose on the genetically distinct MRL/MpJ (MRL) strain. We show by congenic strain analysis that the differences in inner ear phenotypes between MRLAtp6v1b1 vtx/vtx and B6(129S1)-Atp6v1b1 À/À knockout mice are due to strain background differences and not to differences in the natures of their Atp6v1b1 mutations. We exploited these strain-specific differences in a linkage backcross to map loci that modify the degree of hearing loss in Atp6v1b1 vtx/vtx mice and found statistically significant linkage with Chromosome 13 markers. The results of our studies in mice provide insight into the hearing loss variability that is associated with human ATP6V1B1 mutations and suggest that genetic background effects underlie this variation. Because MRL-Atp6v1b1 vtx/vtx mice exhibit enlargements of the endolymphatic sac and duct in the inner ear but do not exhibit the overt metabolic acidosis characteristic of dRTA, they provide a new genetic model for nonsyndromic deafness with enlarged vestibular aqueducts (EVA; OMIM 600791).
Results

Genetic mapping of the vtx mutation
The vortex (vtx) mutation arose spontaneously in a colony of MRL/MpJ (MRL) mice at The Jackson Laboratory. Mice homozygous for vtx are healthy and fertile with normal growth, but they exhibit vestibular dysfunction as evidenced by variable head tilting and circling behaviors, and they are profoundly hearing impaired as shown by ABR analysis (Fig. 1A) . We first attempted to genetically map vtx by generating an intercross of MRL-vtx mice with B6 mice; however, the cross was terminated because no abnormal vestibular-related behaviors were observed in multiple litters of F2 progeny from this cross. A second linkage intercross then was made with F1 hybrids between MRL-vtx/vtx mice and FVB/NJ (FVB) strain mice. Although the number of mutant (vtx/vtx) F2 progeny from this intercross, identified by elevated ABR thresholds, was less than expected, 18 were eventually produced (out of a total of 164 F2s) and used for a genome-wide linkage screen with MIT microsatellite markers that differed in size between MRL and FVB. Results of this low-resolution screen indicated linkage of the vtx phenotype with markers D6Mit15 (17% recombination) and D6Mit366 (11% recombination) on Chr 6.
To verify and refine this linkage association, a backcross of (MRL-vtx/vtx x FVB) F1 hybrids to MRL-vtx/vtx mice was used to generate a total of 101 N2 progeny. Presumed genotypes (þ/vtx or vtx/vtx) of the N2 mice were assigned according to their ABR thresholds. The distribution of ABR thresholds among N2 mice was strongly bimodal (Fig. 1B) as expected for a primarily monogenic trait. About half (59) of the 101 N2 backcross mice had 16 kHz thresholds equal to or less than 30 dB SPL (assigned þ/vtx genotypes) and about half (42) had thresholds equal to or greater than 40 dB SPL (assigned vtx/vtx genotypes). Thresholds for 8 and 32 kHz stimuli were also analysed to reinforce genotype assignments. The wide range of ABR thresholds among N2 mice in the vtx/vtx category (Fig. 1B) suggests the influence of strain-specific modifiers, which may explain why so few mutant phenotypes were observed in progeny from the (MRL x FVB)-þ/ vtx intercross. The N2 mice then were genotyped for multiple polymorphic SNP markers on Chr 6, and haplotype analysis refined the vtx candidate region to the interval between rs13478778 (Chr6: 58,317,346 bp; GRCm38) and rs3708822 (Chr6: 89,292,518 bp).
Gene identification and molecular characterization of the vtx mutation The 31 Mb candidate region for the vtx mutation contains the Atp6v1b1 gene (Chr6: 83,742,990 bp-83,758,855 bp), which encodes the B1 subunit of the vacuolar H þ -ATPase. We considered Atp6v1b1 a good candidate gene for the vtx mutation because (1) it is expressed in the inner ear (2), mutations of the human ATP6V1B1 and ATP6V0A4 genes cause dRTA and deafness, and (3) the inner ear phenotype of vtx/vtx mutant mice is similar to that of Atp6v0a4 knockout mice (6, 7) . The genomic DNA sequences of all 14 Atp6v1b1 exons and their flanking splice sites in MRL-vtx/vtx mutant mice were compared with those of MRL wildtype controls and revealed a single base pair mutation in exon 3 (c.233G > A) that changes the codon for glycine (GGC) to a codon for aspartic acid (GAC) at amino acid position 78 (p.G78D) of the mouse protein (Fig. 2) . DNA sequence analysis of exon 3 in additional mutant (N ¼ 15) and non-mutant (N ¼ 7) mice confirmed this variant to be the recessive Atp6v1b1 vtx mutation.
The vtx missense mutation occurs in the N-terminal domain of ATP6V1B1 (InterPro: IPR004100). The early onset, profound hearing impairment of Atp6v1b1 vtx/vtx mice on the MRL strain background (Fig.1A) is littermate controls. The swelling was especially apparent in the endolymphatic sac and duct, but also noticeable in the utricle, saccule, and cochlear duct (Fig. 3A) . The enlargement of the membranous labyrinth in inner ears of MRL-Atp6v1b1 vtx/vtx mutant mice became even more pronounced at P1 (Fig. 3B) . Cleared whole-mount preparations of inner ears from newborn MRLAtp6v1b1 vtx/vtx mice showed an obvious enlargement of the cochlear duct but also showed a conspicuous deficiency and dispersion of utricular and saccular otoconia compared with MRL-Atp6v1b1 þ/vtx littermate control mice (Fig. 3C ). Whole mount preparations of inner ears from B6.MRL-Atp6v1b1 vtx/vtx mice showed normal morphology, indistinguishable from that of the parental B6 strain mice. Cross-sections of plastic-embedded adult (2.5-4.5 monthsof-age) cochleae (Fig. 4) revealed differences in the arrangement Reissner's membrane pressed up against the walls of the boney labyrinth, nearly eliminating scala vestibuli. Spiral ligament was extremely thin throughout the cochlea. Type I and III fibrocytes were almost entirely missing behind the stria. The stria was also typically thin, especially basally, yet overall, strial structure appeared largely preserved. Most noteworthy was the frequent absence of the boney interscalar septum between the lower cochlear base and lower apical turn. The septum appeared fused with the osseous spiral lamina of the adjacent cochlear regions. Inner hair cells were mostly preserved in the mutants, as were afferent neurons, except in the two extreme the presence, principally in the saccule, of few but very large otoconia that tended toward triangular shapes. These were often associated with possible macrophages. Perhaps due to faulty attachment, the large otoconia were observed in cochlear scala media in 5 of 9 mutants. No otoconia were observed covering the utricular maculae, although it cannot be ruled out that these were more prone to migrate during processing. ABR thresholds of adult mice (2.5 and 4.5 months of age) were compared for 5, 10, 20, 28.3, 40, and 56.6 kHz test stimuli (Fig. 6A) mice were healthy and showed no overt symptoms of metabolic acidosis. The previously reported B6(129S1)-Atp6v1b1 knockout mice show increased urine pH, decreased calcium excretion, and decreased urine osmolality (9) . We measured these characteristics in the MRL-Atp6v1b1 vtx/vtx and B6.MRL-Atp6v1b1 vtx/vtx mice and compared them with wildtype mice from the same genetic background. Similar to results reported for mice with the Atp6v1b1 knockout mutation, mice homozygous for the Atp6v1b1 vtx mutation on the B6 background had a significantly higher urine pH (6.5 6 0.1 vs 6.2 6 0.1) compared to wildtype B6 mice (Fig. 7A ). We did not observe a difference between wildtype and Atp6v1b1 vtx/vtx mutant mice on the MRL background, but wildtype MRL mice had an unusually high urine pH (6.5 6 0.2) /Cr mg/g ratios) was observed in mice with the Atp6v1b1 vtx mutation in both genetic backgrounds (Fig. 7B ) although we saw a larger decrease (163.3 6 17.4 vs. 45.9 6 6.0l, approx. 70%) in the MRL background compared to the B6 background (139.2 6 9.1 vs. 99.0 6 9.6, approx. 30%). We did not measure a significant effect of the Atp6v1b1 vtx mutation on urine osmolality on either background.
In addition, we also measured potassium, sodium, and chloride concentrations in both blood and urine and did not find any significant differences between Atp6v1b1 vtx/vtx and wildtype mice on either strain background (Table 1) .
Genetic mapping of hearing loss modifiers
To genetically map loci that contribute to hearing loss differences between B6.MRL-Atp6v1b1 vtx/vtx and MRL-Atp6v1b1 (Fig. 9A ).
To verify and refine this linkage, we analysed all 102 N2 mice for six SNP markers spanning Chr 13 using an interval mapping approach (Fig. 9B) . The most likely candidate region for modifier gene(s) on this chromosome was found to be between rs3719347 (39.5 Mb position, GRCm38) and rs3023390 (96.7 Mb), with rs3654821 (63.1 Mb) having the highest association (LOD 5.4 for 16 kHz thresholds). Segregation at this locus accounts for about 20% of the total threshold variation in the backcross mice. Interval mapping in 1 cM increments showed that slightly higher associations (max LOD 6.1) could be obtained for hypothetical loci about 8 cM on either side of rs3654821 (Fig. 9B) . ABR thresholds of backcross mice homozygous for MRL-derived alleles (genotype M/M) at the rs3654821 locus were about 20 dB higher than those of mice heterozygous for B6 and MRL alleles (genotype B/M, Fig. 9C ). Mean thresholds of mice with B/M (N ¼ 50) and M/M (N ¼ 52) rs3654821 genotypes were statistically significantly different at all test frequencies (two-tailed Student's t-Test probabilities < 0.00001).
The most likely location for the Chr 13 modifier of hearing loss in the backcross mice is in the 39.5-96.7 Mb region (Fig. 9B) . Within this large 57 Mb region, which contains about 400 protein-coding genes, we selected two candidates for further testing, Slc9a3 and Slc12a7, because they are expressed in the inner ear and are known to be involved in ion homeostasis. Strong expression of the sodium hydrogen exchanger NHE3 (the protein encoded by Slc9a3) was demonstrated in the apical membrane of strial marginal cells (12) , and H þ flux from this exchanger may play a role in controlling acid-base balance in cochlear endolymph (13) . A knockout mutation of Slc12a7, which encodes the KCC4 member of the K þ -Cl -cotransporter family, was shown to cause deafness and renal tubular acidosis; however, the endolymphatic compartments of Slc12a7 À/À inner ears
were not enlarged (14) . We sequenced the 16 exons of Slc9a3 and the 24 exons of Slc12a7 along with their flanking splice sites in DNA from MRL mice and compared them to the reference sequence of the B6 strain, but found no differences except for two synonymous SNP variants detected in exons 11 and 13 of Slc9a3, which previously have been identified in other inbred strains. The two candidate genes also were examined by quantitative RT-PCR to evaluate and compare their mRNA expression levels in inner ear tissue of MRL and B6 mice at 2 weeks of age. We did not detect any differences in expression levels of these genes between MRL and B6 mice using the comparative delta-Ct method. The calculated fold changes (relative to the mean B6 value) in Slc12a7 expression were 0.94 (range 0.78-1.13) for MRL and 1.00 (range 0.59-1.68) for B6, and the mean delta Ct values were not significantly different (P ¼ 0.81). The calculated fold changes in Slc9a3 expression were 1.04 (range 0.77-1.41) for MRL and 1.00, (range 0.82-1.22) for B6, and the mean delta Ct values were not significantly different (P ¼ 0.87).
Discussion
We present six lines of evidence in support of the Atp6v1b1 p.G78D missense mutation as the pathogenic variant underlying the vtx/vtx phenotype. 1) The vtx mutation was mapped to a 31 Mb chromosomal region that includes the Atp6v1b1 gene. 2) There was complete concordance of the vtx/vtx phenotype with homozygosity for the Atp6v1b1 missense mutation in all mice examined. 3) Because vtx is a new spontaneous mutation that occurred on the genetically homogenous MRL inbred strain, the Atp6v1b1 missense mutation is expected to be the only DNA difference with the parental MRL strain, thereby precluding the possibility of linkage disequilibrium with other variants. 4) The inner ear phenotype of vtx/vtx mice is very similar to that of mice with a knockout mutation of Atp6v0a4
, a gene that also encodes a vH þ -ATPase subunit expressed in the inner ear. 5) The glycine altered by the Atp6v1b1 vtx missense mutation is evolutionarily highly conserved, and both the SIFT (http://sift. jcvi.org/) and PolyPhen 2 (http://genetics.bwh.harvard.edu/ pph2/) computer programs predict that the p.G78D substitution is probably damaging to protein function. 6) Members of two different Turkish families who present with dRTA and sensorineural hearing loss are homozygous for a missense mutation of the corresponding amino acid (p.G78R) in the human ATP6V1B1 protein (15, 16) .
Evidence from rat kidney cell culture experiments suggests that point mutations in B1 subunits may cause dysfunction by inhibiting the normal trafficking of vH þ -ATPase to the apical membrane (17) . If mutant B1 subunits cannot assemble into the native vH þ -ATPase complex, they might compete for molecules necessary for trafficking of the compensatory B2 subunit to the apical membrane (10) . If so, the vtx missense mutation might be more damaging than the knockout mutation, and this may account for the phenotypic differences between Atp6v1b1 À/À and (20) . Mutations of these genes impede fluid absorption in the ES causing endolymph build up and dilatation of the membranous labyrinth (21, 22) ; however, the molecular mechanisms underlying these effects are not fully understood. According to one proposed mechanism (21), mutations of these genes reduce the ES epithelium-generated H þ current that normally forces Na þ transport and fluid movement out of the ES lumen. The hearing loss, vestibular dysfunction, and other inner ear abnormalities of these mutant mice are thought to be consequences of this disrupted fluid homeostasis in the ES during embryonic development (22) .
Paintfills of the membranous labyrinths of P1 inner ears of MRL-Atp6v1b1
vtx/vtx mice (Fig. 3B ) and P0 inner ears of (Fig. 4) do not show these features, although they do show an overall increase in the dimensions of the cochlear capsule. One hypothesis to explain these differences is that an enlarged capsule was formed during the period when the membranous labyrinth was in an expanded state (Fig. 3B) , followed by a subsequent reduction in endolymph volume at older ages (perhaps after loss of stria vascularis function), resulting in reduced size of the scala media and non-distended Reissner's membrane (Fig. 4) . Based on appearance (Fig. 5) (Table 1) , which agrees with the findings for the Atp6v1b1 À/À knockout mouse with compensated acidosis (8) . In contrast, the Atp6v0a4 À/À mouse with severe metabolic acidosis has significantly lower concentrations of K þ and Cl -in the blood than controls (7) . Although the mild renal phenotype of MRLAtp6v1b1 vtx/vtx mice is similar to that of Atp6v1b1 À/À mice, its severe inner ear phenotype is similar to that of Atp6v0a4 À/À mice.
The difference in severity between the inner ear and kidney phenotypes of MRL-Atp6v1b1 vtx/vtx mice may be due to modifying genetic factors that have stronger effects on H þ transport and ion homeostasis in the inner ear than in the kidney tubule. Not all cases of dRTA caused by ATP6V1B1 mutations have associated hearing loss (4), which lends support to the idea that inner ear and kidney-related pathologies are not always coupled.
In an attempt to identify genetic factors that contribute to the different inner ear phenotypes of MRL-Atp6v1b1 vtx/vtx and B6.MRL-Atp6v1b1 vtx/vtx mice, we analysed ABR threshold associations in a linkage backcross involving these two strains. Thresholds of Atp6v1b1 vtx/vtx progeny from the backcross showed a broad distribution with mostly intermediate values rather than a bimodal distribution with two discreet groupings of more extreme values (Fig. 8B ), indicating contributions from multiple genes. The large variation and wide range of ABR thresholds observed in genetically identical MRL-Atp6v1b1 vtx/vtx x B6.MRL-Atp6v1b1 vtx/vtx F1 hybrids (Fig. 8) demonstrates discordance between genotype and phenotype that also contributed to the difficulty in mapping modifier genes. A genome-wide linkage screen detected statistically significant associations only with Chr 13 markers (Fig. 9A) , but even the highest association at this locus could account for only about 20% of the total ABR threshold variation in the backcross mice. Together, these results suggest a complex genetic basis for the difference in MRL and B6 strain background effects on hearing thresholds of Atp6v1b1 vtx/vtx mice, with multiple contributing genes each having relatively small effects. We examined two interesting candidate modifier genes with known roles in inner ear fluid homeostasis (Slc9a3 and Slc12a7) that lie within the candidate region of Chr 13 (39.5-96.7 Mb; Fig.  9B ), but did not find any differences in the DNA sequences of their exons or in their mRNA expression levels in P14 inner ear tissue. Although our inner ear dissections did not include the endolymphatic sac, neither candidate gene shows expression in this tissue; Slc9a3 being limited to the stria vascularis (12) and Slc12a7 to the stria vascularis and organ of Corti supporting cells (14) . Our results, however, do not rule out the possibility that non-coding sequence differences in these genes might cause subtle expression differences during inner ear development that we did not detect in two-week-old mice. Of course, one or more of the many other genes in the candidate region could also be responsible for the Chr 13 modifier effect. For example, the uncharacterized Atp6ap1l gene is predicted to encode a protein with similarities to ATP6AP1, an accessory subunit of the vH þ -ATPase complex, which has been implicated as a regulator of vH þ -ATPase function in the neuroendocrine secretory pathway (24) , suggesting the possibility that ATP6AP1L may play a similar regulatory role in the inner ear.
Urine pH and calcium excretion were not measured in the linkage backcross mice although they showed significant differences between strains and genotypes (Fig. 7) , and it is possible these differences may co-vary with ABR thresholds. If so, then genes located in the Chr 13 candidate region that are not known to affect inner ear function but are known to play a role in kidney function, such as Slc34a1, may also be considered as candidate modifiers of the Atp6v1b1 phenotype.
Our results clearly establish that genetic background differences can have a profound effect on the auditory phenotypes associated with Atp6v1b1 mutations in mice and suggest that similar genetic background effects could contribute to the phenotypic variability associated with human ATP6V1B1 mutations. Human cases of dRTA are reported to have variable degrees of inner ear abnormalities (25) and hearing loss (4) . Determining the genetic causes underlying the phenotypic differences among mouse Atp6v1b1 mutations on different strain backgrounds may shed light on the underlying causes of this clinical heterogeneity.
Enlargement of the vestibular aqueduct (EVA, OMIM 600791), the bony canal that encloses the endolymphatic duct, is a common inner ear malformation diagnosed in children with hearing loss (https://www.nidcd.nih.gov/health/enlarged-vestibular-aq ueducts-and-childhood-hearing-loss). High resolution computed tomography studies have detected bilaterally enlarged vestibular aqueducts in patients with autosomal recessive dRTA and deafness (25, 26) . The combination of EVA and hearing loss is also characteristic of several other syndromes, including Pendred, branchio-oto-renal, CHARGE, and Waardenburg syndromes (27) . Pendred syndrome, caused by mutations of SLC26A4, does not always present with thyroid goiter, and these cases constitute the major known underlying cause of nonsyndromic EVA and hearing loss. Because 50% of European or North American Caucasian individuals with EVA-associated hearing loss have no obvious SLC26A4 mutations (28) , mutations of other as yet unidentified genes are thought to be responsible for some of the remaining unknown cases. Variants of KCNJ10 and FOXI1 have been proposed to underlie some of these cases (29, 30) , but contradictory results have been reported in other studies (31) (32) (33) . MRL-Atp6v1b1 vtx/vtx mutant mice are deaf with enlarged endolymphatic compartments of the inner ear but do not recapitulate the overt metabolic acidosis characteristic of dRTA. They thus provide a new genetic model for nonsyndromic deafness with EVA and suggest that mutations in the human ATP6V1B1 gene might account for some of the unknown genetic cases of this disorder that are not associated with SLC26A4 mutations. A C57BL/6J (B6) congenic strain carrying the vtx mutation was generated by first mating MRL-Atp6v1b1 vtx/vtx mice with B6 mice to produce F1 hybrids, followed by repeated backcrosses to B6 mice, at each generation selecting hybrids heterozygous for the MRL-derived Atp6v1b1 vtx mutation (inferred by the presence of MRL alleles at flanking markers D6Mit144 and D6Mit29). N10 generation Atp6v1b1 þ/vtx mice were then inbred, and the MRL- Genetic mapping and DNA analysis of the vtx mutation
Materials and Methods
Mice
To genetically map the vtx mutation, individual DNA samples from linkage cross mice were typed for multiple MIT microsatellite markers located throughout the mouse genome. Previously described PCR methods (34) were used to genotype the chromosomal markers, which were then analysed for co-segregation with the mutant phenotype. PCR primer pairs designed to amplify specific markers were purchased from Integrated DNA Technologies (Coralville, IA, USA). PCR for comparative DNA analysis between vtx/vtx mutant and control mice was performed according to the same conditions as described above for genetic mapping. PCR primers used to identify the vtx mutation of the Atp6v1b1 gene for genotyping were 5'-GATCCCCTTCTCCACATCAG -3' (forward) and 5'-AGCATGGTCTATGTGCTGGG -3' (reverse). The expected PCR product size (590 bp) was confirmed on a 3.5% agarose gel. PCR products then were purified with the QIAquick PCR Purification Kit (Qiagen Inc., Valencia, CA), and sequenced on an Applied Biosystems 3700 DNA Sequencer with an optimized Big Dye Terminator Cycle Sequencing method. Typical DNA sequencing results for distinguishing Atp6v1b1 wildtype and vtx mutant alleles are shown in Figure 2A .
Auditory brainstem response (ABR) measurements
At the Jackson Laboratory, ABR thresholds were measured at 8, 16 and 32 kHz in a sound attenuating chamber using the SmartEP auditory evoked potential diagnostic system from Intelligent Hearing Systems (IHS, Miami, FL) as described previously (35) . Briefly, mice were anesthetized with tribromoethanol (0.2 ml of 20 mg/ml stock per 10 g of body weight, i.p.) and placed on a temperature controlled heating pad to maintain body temperature at 37 C. Output tubes from high frequency transducers were snugly fit in the ear canals of the mouse. Both ears were tested simultaneously, which effectively measures the thresholds of the better responding ear. Three subdermal electrodes, placed at the vertex and behind each ear, were used to record brain stem responses to defined tone-bursts (3 ms duration. 1.5 ms cosine-gated rise/fall time). The responses were then amplified, filtered (100-3000 Hz) and averaged (25 kHz sampling rate, 10 ms analysis window). Stimulus intensity was initially decreased in 10 dB steps until the response began to disappear and then lowered in 5 dB steps; ABR threshold was defined as the lowest intensity at which an ABR response could be reliably obtained. With our testing system, average ABR thresholds for normal hearing mice are about 40, 20, and 45 dB SPL for 8, 16 and 32 kHz stimuli, respectively. Data from ABR tests at the Jackson Laboratory are shown in Figures 1 and 8 . At Washington University School of Medicine (WUSM), ABR measurements were performed in a foam-lined, single-walled soundproof room (IAC). Animals were anesthetized (80 mg/kg ketamine, 15 mg/kg xylazine, IP) and positioned dorsally in a custom head holder. Core temperature was maintained at 37.5 6 1.0 C using a DC electric heating pad in conjunction with a rectal probe (FHC). Platinum needle electrodes (Grass) were inserted subcutaneously just behind the right ear (active), at the vertex (reference), and in the back (ground). Electrodes were connected to a Grass P15 differential amplifier (300-3,000 Hz, Â100), then to a custom amplifier providing another 1,000X gain, then digitized at 30 kHz and visualized using Tucker Davis Technologies (TDT) System 2 hardware and software. Sine wave stimuli having 0.5 ms cos 2 rise/fall times and 5.0 ms total duration were also generated and calibrated using TDT System2 
Tissue processing and imaging for histopathology
At the end of ABR and EP recordings at WUSM, animals were overdosed and perfused transcardially with cold 2.0% paraformaldehyde/2.0% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4). Each cochlea was rapidly isolated, immersed in the same fixative, and the stapes was immediately removed. After decalcification in sodium EDTA for 72 h, cochleae were post-fixed in buffered 1% osmium tetroxide, dehydrated in an ascending acetone series, and embedded in Epon. Cochleae were sectioned parallel to the modiolus at 4.0 mm, then stained with toluidine blue for bright field viewing. All auditory and vestibular epithelia were examined qualitatively in initially three inner ears (three animals) per genotype. Due to the heterogeneity in appearance of the inner ears of MRL-Atp6v1b1 vtx/vtx mice, 9 were examined in serial detail, so that central tendencies could be discerned. Bright field images used for illustration were obtained on a Zeiss LSM 700 laser scanning confocal microscope using ZEN TM software.
Inner ear paint fills and cleared whole mount preparations , n ¼ 5) were used for inner ear paint fills. E15 embryos were decapitated and whole heads were fixed in Bodian's fixative. P1 mice were decapitated and half-heads were fixed in Bodian's fixative after the brain was removed. Heads were fixed overnight and then dehydrated with 75% ethanol (2 Â 2 h), 95% ethanol (2 Â 2 h), and 100% ethanol (2 Â2 h). Heads were then rinsed once with methyl salicylate and cleared overnight by placing specimens in methyl salicylate. Inner ears were filled with 1% Wite-Out correction fluid in methyl salicylate using a Hamilton syringe, with a pulled glass capillary needle broken to a tip diameter of 20-40 lm. E15 inner ears were injected through the middle turn of the cochlea. Two injections were done for P1 inner ears with one injection to the cochlear middle turn and the second injection in the common crus (Kiernan, 2006) . To observe otoconia, inner ears dissected from bisected heads of P1 mice were cleared with methyl salicylate as described above, sub-illuminated and photographed using a Leica dissecting microscope.
Blood and urine analysis
At 17 weeks of age spot urine and blood were collected from 5 males of each group. Immediately after collection, urine pH was measured by using a glass pH electrode (Thermo Orion Micro pH Probe). Sodium, potassium, and chloride were measured in urine and blood, calcium and creatinine were measured in urine on a Beckman AU680 Chemistry analyzer. Osmolality of blood and urine was measured using a 5004 micro-Osmette (Precision Systems).
Genetic mapping of modifier loci
For linkage backcross analysis to map modifier loci, tail-tip samples from individual N2 progeny mice were provided to the Jackson Laboratory's Genotyping Service, which outsources SNP genotyping to LGC Genomics (Beverly MA). Each mouse DNA sample was genotyped for 120 selected SNPs that differ between the B6 and MRL strains. The ABR thresholds of the same backcross mice were evaluated as quantitative traits, and the MapManager QTXb20 program of least-squares linear regression (11) was used to analyse linkage and identify marker associations with ABR thresholds.
Analyses of candidate modifier genes
DNA and cDNA sequencing of candidate genes was performed on an Applied Biosystems 3700 DNA Sequencer with an optimized Big Dye Terminator Cycle Sequencing method, and the sequencing results were analysed with Sequencher DNA Sequence Analysis Software (Gene Codes Corporation, Ann Arbor, MI, USA).
For qRT-PCR analysis of candidate gene expression, inner ears were dissected from two-week-old MRL-Atp6v1b1 , and B6 wild-type mice and snap frozen in liquid nitrogen. Inner ear tissues did not include the endolymphatic sac, which was lost during the dissection process. The two inner ears of each mouse were pooled together and homogenized in 1 ml TRIzol (Life Technologies) in GentleMACS M-tubes (Miltenyi Biotech) using a GentleMACS dissociator. Homogenates were briefly centrifuged to pellet and remove cell debris. Homogenates were phase separated in 1/5 volume of chloroform. RNAs were extracted using the MagMAX mirVana Total RNA Isolation Kit (Life Technologies) following the manufacturer's recommendations on the KingFisher Flex Purification System (Thermo Fisher Scientific). RNA quantity and quality were assessed using a Nanodrop 2000 (Thermo Scientific) and Bioanalyzer 2100 (Agilent) respectively. RNA was reverse-transcribed into cDNA using 500 ng total RNA and the Superscript IV First-Strand Synthesis System (Thermo Fisher Scientific) following the manufacturer's recommendations. cDNA was diluted 1:5 with RNase-free water, and 2 ll of was used for quantitative realtime PCR (qPCR) using a standard SYBR green comparative Ct template on a Life Technologies ViiA7 qPCR machine. Primer sequences were ATCCTTTTCCTGCGTCTGAC-forward and CTCAT GGAGATGGCTGTCAG-reverse (110 bp product) for Slc12a7 and AGGTGGTCACCTTCAAATGG-forward and ACCTTGTGGGACA GGTGAAA-reverse (106 bp product) for Slc9a3; both primer pairs produced robust single band products on agarose gels. The double delta-Ct method was used to calculate fold changes in expression levels, and statistical analysis comparing mean delta Ct values was done with the two-tailed student test.
